Methimazole and propylthiouracil induced acute toxic hepatitis;Hepatitis aguda tóxica por metimazol y propiltiouracilo

Gastroenterologia y Hepatologia

Volumn 30, Issue 5, 2007, Pages 268-270

  Blanco, Sonia Casallo ^a   Valero, Miguel Ángel ^a   Marcos Sánchez, Fernando ^a   Salces, Laura De Matías ^a   González, José Javier Blanco ^a   Barranco, María José Martín ^a  

^a HOSPITAL NUESTRA SEÑORA DEL PRADO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; PROPRANOLOL DERIVATIVE; PROPYLTHIOURACIL; THIAMAZOLE;

ACUTE HEPATITIS; AGED; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; HUMAN; LABORATORY TEST; LIVER TOXICITY; MALE; OBSTRUCTIVE JAUNDICE; PHYSICAL EXAMINATION;

EID: 34250339312     PISSN: 02105705     EISSN: None     Source Type: Journal    
DOI: 10.1157/13101979     Document Type: Article

References (19)

1. Singer PA, Cooper DS, Levy EG, Ladenson PW, Braverman LE, Daniels G. Treatment guidelines for patients with hyperthyroidism and hypothyroidism. JAMA. 1995;273:808-12.
2. Lanzarous JH. Hyperthyroidism. Lancet. 1997;349:339-43.
3. a. ed. Madrid: Elsevier; 2005. p. 411-64.
4. Cooper DS. Antithyroid drugs. N Engl J Med. 2005;352:905-17.
5. Cooper DS. The side effects of antithyroid drugs. Endocrinologist. 1999;9:457-76.
6. Werner MC, Romaldini JH, Bromberg N, Werner RS, Farah CS. Adverse effects related to thionamide drugs and their dose regimen. Am J Med Sci. 1989;297:216-9.
7. Cooper DS. Antithyroid drugs in the management of patients with Graves's disease: an evidence-based approach to therapeutic controversies. J Clin Endocrinol Metab. 2003;88:3474-81.
8. Woeber K. Methimazole-induced hepatotoxicity. Endocr Pract. 2002;8:222-4.
9. Mikhail NE. Methimazole-induced cholestatic jaundice. South Med J. 2004;97:178-82.
10. Piñero Madrona A, Pons Miñano JA, Madrid Conesa J, Parrilla Paricio P. Hepatitis por metimazol. Rev Clin Esp. 2004;204: 388.
11. Huang MJ, Li KL, Wei JS, Wu SS, Fan KD, Liaw YF. Sequential liver and bone biochemical changes in hyperthyroidism: prospective controlled follow-up study. Am J Gastroenterol. 1994; 89:1071-6.
12. Arab DM, Malatjalian DA, Rittmaster RS. Severe cholestatic jaundice in uncomplicated hyperthyroidism treated with methimazole. 1995;80:1083-5.
13. Williams KV, Nayak S, Becker D, Reyes J, Burmeister LA. Fifty years of experience with propylthiouracil-associated hepatotoxicity: What have we learned? J Clin Endocrinol Metab. 1997;82:1727-33.
14. Pérez-Carreras M, Lamela MP, Galera G, Solís-Herruzo JA. Colestasis intrahepática por metimazol. Endocrinol Nutr. 2003; 50:345-7.
15. Solá izquierdo E, Morillas Ariño C, Peña Guillermo H, Muñoz Ferrer ML, Morillas Ariño J, Hernández Mijares A. Hepatitis colestásica por metimazol. Endocrinol Nutr. 2002;49:127-9.
16. Cooper DS.1996. Treatment of thyrotoxicosis. En: Braverman LE, Utiger RD, editors. Werner and Ingbar's the thyroid. 7th ed. Philadelphia: Lippincott-Raven; 2004. p. 713-34.
17. Hung YT, Yu WK, Chow E. Delayed cholestatic hepatitis due to methimazole. Hong Kong Med J. 1999;5:200-1.
18. Woeber KA. Update on the management of hyperthyroidism and hypothyroidism. Arch Intern Med. 2000;160:1067-71.
19. Kontoleon P, Ilias I, Koutras DA, Kontogiannis D, Papapetrou PD. Sucessful treatment with carbimazole of a hyperthyroid pregnancy with hepatic impairment after propylthiouracil administration: a case report. Clin Exp Obstet Gynecol. 2002;29: 304-5.